| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 22.30B | 21.26B | 21.73B | 23.00B | 22.64B | 21.38B |
| Gross Profit | 2.86B | 2.50B | 2.26B | 2.29B | 1.91B | 1.97B |
| EBITDA | 1.59B | 1.28B | 1.35B | 1.22B | 880.53M | 777.63M |
| Net Income | 1.11B | 1.06B | 625.55M | 1.12B | 866.61M | 644.07M |
Balance Sheet | ||||||
| Total Assets | 19.93B | 21.42B | 21.98B | 20.82B | 17.49B | 17.11B |
| Cash, Cash Equivalents and Short-Term Investments | 4.08B | 3.81B | 3.92B | 3.36B | 1.32B | 767.21M |
| Total Debt | 1.79B | 1.87B | 1.83B | 1.82B | 1.09B | 1.77B |
| Total Liabilities | 8.63B | 10.78B | 12.06B | 11.09B | 8.51B | 8.94B |
| Stockholders Equity | 11.08B | 10.42B | 9.71B | 9.50B | 8.74B | 8.00B |
Cash Flow | ||||||
| Free Cash Flow | -404.19M | 784.62M | 1.85B | 812.75M | 220.34M | 389.36M |
| Operating Cash Flow | -131.45M | 1.04B | 2.49B | 2.00B | 1.57B | 990.37M |
| Investing Cash Flow | -82.22M | -1.50B | -1.46B | -152.99M | -103.93M | -676.72M |
| Financing Cash Flow | -393.26M | -356.46M | -478.02M | 185.09M | -911.40M | -879.07M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | HK$11.24B | 7.77 | 11.27% | 3.66% | -0.34% | 64.10% | |
71 Outperform | HK$14.09B | 10.97 | 9.60% | 3.23% | 0.82% | 2.99% | |
70 Outperform | HK$13.37B | 10.56 | 5.19% | 5.44% | -8.24% | -24.53% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | HK$1.20B | 18.52 | 2.55% | 3.52% | -5.29% | -32.47% | |
59 Neutral | HK$1.24B | 7.69 | 7.36% | 2.20% | -8.51% | -68.34% | |
40 Underperform | HK$618.98M | -57.48 | -8.95% | ― | -5.79% | -129.73% |